Afuco™ Anti-TNFRSF9 ADCC Recombinant Antibody (Urelumab), ADCC Enhanced (CAT#: AFC-TAB-179)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to 4-1BB. Urelumab (ue rel' ue mab; also known as BMS-663513 and anti-4-1BB antibody) is a fully human IgG4 monoclonal antibody for the treatment of cancer and solid tumors.
Urelumab targets the CD137 receptor. It specifically binds to and activates CD137-expressing immune cells, stimulating an immune response, in particular a cytotoxic T cell response, against tumor cells.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
RNA Expression

Specifications

  • Immunogen
  • Ectodomain of human 4-1BB recombinant protein.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Clone
  • Urelumab
  • Applications
  • ELISA, FC, IP, FuncS, IF, Neut
  • Conjugate
  • Unconjugated
  • Generic Name
  • Urelumab
  • Related Disease
  • Tumors

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Urelumab; 934823-49-1; BMS-663513; BMS-663513; TNFRSF9; tumor necrosis factor receptor superfamily, member 9; ILA; tumor necrosis factor receptor superfamily member 9; 4 1BB; CD137; CD137 antigen; T cell antigen ILA; T-cell antigen ILA; 4-1BB ligand receptor

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Urelumab"

Anti-Human 4-1BB Recombinant Antibody (Urelumab)
Recombinant monoclonal antibody to 4-1BB. Urelumab (ue rel' ue mab; also known as BMS-663513 and anti-4-1BB antibody) is a fully human IgG4 monoclonal antibody for the treatment of cancer and solid tumors.
Urelumab targets the CD137 receptor. It specifically binds to and activates CD137-expressing immune cells, stimulating an immune response, in particular a cytotoxic T cell response, against tumor cells.

See other products for "Clone Urelumab"

See other products for "TNFRSF9"

Select a product category from the dropdown menu below to view related products.
Please select product type
Human Antibody Products Immunotoxin Products Fc Glycosylation Antibody Products High-mannose Glycoform Antibody Products Humanized Antibody Products Chimeric Antibody Products Blocking Antibody Products Neutralizing Antibody Products IgG Antibody Products Fab Antibody Products ADCC Enhanced Antibody Products ScFv Antibody Products Agonistic Antibody Products Non-Human Primate (NHP) Antibody Products
CAT Product Name Application Type
TAB-179 Anti-Human 4-1BB Recombinant Antibody (Urelumab) ELISA, FC, IP, FuncS, IF, Neut, ICC IgG4 - kappa
TAB-457CQ Anti-Human TNFRSF9 Recombinant Antibody (Utomilumab) ELISA, IHC, FC, IP, IF, FuncS IgG2, λ

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-179. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare